loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering 8604064

    Client Virtual Booth
    Menu

    AstraZeneca

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ASTRAZENECA (2)

    filter

    01 8604064 (2)

    filter

    01 Blank (2)

    filter

    01 Blank (2)

    filter

    01 2024-03-08 (2)

    refreshReset Filter
    refreshReset Filter
    price-trendAsk Us

    ASTRAZENECA

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ROFLUMILAST

    PDF Supplier PDF
    URL Supplier Web Content
    8604064
    2024-03-08
    U-1115
    22522
    TREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ASTRAZENECA

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ROFLUMILAST

    PDF Supplier PDF
    URL Supplier Web Content
    8604064
    2024-03-08
    U-1115
    22522
    TREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY